,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Pain in extremity,3,16710382
1,22.1,White blood cell count decreased,6,16710382
2,22.1,Immune system disorder,6,16710382
0,22.1,Weight decreased,6,16710428
1,22.1,Transfusion,6,16710428
0,22.0,Product dose omission,3,16710455
1,22.0,Hypersomnia,3,16710455
2,22.0,Rash erythematous,3,16710455
3,22.0,Headache,3,16710455
4,22.0,Neck pain,3,16710455
5,22.0,Mobility decreased,3,16710455
6,22.0,Somnolence,3,16710455
7,22.0,Back pain,3,16710455
8,22.0,Feeling abnormal,3,16710455
9,22.0,Aggression,3,16710455
10,22.0,Fall,3,16710455
11,22.0,Paranoia,3,16710455
0,22.1,Hair disorder,3,16710458
1,22.1,Alopecia,3,16710458
2,22.1,Hair texture abnormal,3,16710458
3,22.1,Hair colour changes,3,16710458
4,22.1,Madarosis,3,16710458
0,22.1,Limb discomfort,6,16710464
1,22.1,Memory impairment,6,16710464
2,22.1,Nasopharyngitis,6,16710464
3,22.1,Stomatitis,6,16710464
4,22.1,Pneumonia,6,16710464
5,22.1,Decreased appetite,6,16710464
6,22.1,Glossodynia,6,16710464
7,22.1,Pain in extremity,6,16710464
8,22.1,Gait disturbance,6,16710464
9,22.1,Pain,6,16710464
10,22.1,Mental disorder,6,16710464
11,22.1,Peripheral swelling,6,16710464
0,22.0,Rash,3,16710473
0,22.0,Fatigue,6,16710475
1,22.0,Product dose omission,6,16710475
2,22.0,Headache,6,16710475
3,22.0,Arthropathy,6,16710475
4,22.0,Asthenia,6,16710475
0,22.0,Weight abnormal,6,16710477
0,22.1,Blood creatinine increased,6,16710483
1,22.1,Infection,6,16710483
2,22.1,General physical health deterioration,6,16710483
3,22.1,Obstruction,6,16710483
4,22.1,Neutrophil count decreased,6,16710483
5,22.1,Fibrin D dimer increased,6,16710483
6,22.1,Blood test abnormal,6,16710483
7,22.1,Transfusion,6,16710483
8,22.1,Device occlusion,6,16710483
0,22.0,Lacrimation increased,3,16710491
1,22.0,Skin discolouration,6,16710491
2,22.0,Fatigue,3,16710491
3,22.0,Insomnia,6,16710491
4,22.0,Hair texture abnormal,6,16710491
5,22.0,Alopecia,2,16710491
6,22.0,Memory impairment,6,16710491
0,22.1,Speech disorder,6,16710509
1,22.1,Malaise,6,16710509
0,22.0,Death,5,16710530
0,22.0,Hypothyroidism,1,16710535
0,22.0,Malignant neoplasm progression,5,16710565
0,22.1,Cytopenia,6,16710568
0,22.0,Tachycardia,1,16710574
1,22.0,Hypotension,1,16710574
0,22.0,Chronic lymphocytic leukaemia,6,16710575
1,22.0,Stomatitis,6,16710575
2,22.0,Back pain,6,16710575
3,22.0,Hot flush,6,16710575
4,22.0,Intervertebral disc protrusion,6,16710575
5,22.0,Second primary malignancy,6,16710575
6,22.0,Cough,6,16710575
7,22.0,Dyspnoea,6,16710575
8,22.0,Fatigue,6,16710575
9,22.0,White blood cell count decreased,6,16710575
10,22.0,Pruritus,6,16710575
0,22.0,Leukoencephalopathy,2,16710640
0,22.0,Death,5,16710665
0,22.1,Red blood cell count decreased,6,16710691
1,22.1,Neutropenia,6,16710691
2,22.1,Confusional state,6,16710691
3,22.1,Staphylococcus test positive,6,16710691
4,22.1,General physical health deterioration,3,16710691
5,22.1,Pleural effusion,6,16710691
6,22.1,Pancytopenia,3,16710691
7,22.1,Tachycardia,6,16710691
8,22.1,Sepsis,5,16710691
9,22.1,Pneumonia,3,16710691
10,22.1,Fatigue,3,16710691
11,22.1,Insomnia,3,16710691
12,22.1,Weight decreased,3,16710691
13,22.1,Haemoglobin decreased,6,16710691
14,22.1,Hyperthermia,6,16710691
0,22.0,Malignant neoplasm progression,6,16710693
1,22.0,Back disorder,6,16710693
2,22.0,Pain,6,16710693
3,22.0,Pelvic mass,6,16710693
0,22.0,Acute myeloid leukaemia,3,16710699
0,22.0,Colitis ischaemic,2,16710762
0,22.0,Asthenia,3,16710766
1,22.0,Pneumonitis,3,16710766
2,22.0,Pyrexia,3,16710766
3,22.0,Hypoxia,3,16710766
4,22.0,Somnolence,3,16710766
5,22.0,Hypoalbuminaemia,6,16710766
6,22.0,Hyponatraemia,6,16710766
0,22.0,Interstitial lung disease,2,16710778
1,22.0,Toxicity to various agents,2,16710778
0,22.0,Haematotoxicity,6,16710791
1,22.0,Off label use,6,16710791
2,22.0,Malignant neoplasm progression,6,16710791
0,22.0,Product use in unapproved indication,6,16710792
0,22.0,Metastases to bone,6,16710807
1,22.0,Malignant neoplasm progression,6,16710807
0,22.0,Breast cancer,6,16710808
1,22.0,Malignant neoplasm progression,6,16710808
0,22.0,Drug effective for unapproved indication,6,16710834
1,22.0,Product use in unapproved indication,6,16710834
0,22.0,Rash pruritic,6,16710839
1,22.0,Alopecia,6,16710839
0,22.0,Product use in unapproved indication,6,16710842
0,22.0,Oxygen saturation decreased,6,16710886
1,22.0,Chills,1,16710886
0,22.0,Hypoalbuminaemia,5,16710893
0,22.0,Rash,1,16710915
1,22.0,Back pain,1,16710915
2,22.0,Hypertensive crisis,1,16710915
0,22.0,Acute kidney injury,1,16710917
0,22.0,Cholangitis,6,16710947
0,22.1,Upper respiratory tract infection,6,16710952
1,22.1,Nausea,6,16710952
2,22.1,Liver function test abnormal,6,16710952
3,22.1,Orthostatic hypotension,6,16710952
4,22.1,Constipation,6,16710952
5,22.1,Dehydration,6,16710952
6,22.1,Febrile neutropenia,6,16710952
7,22.1,Bladder neck obstruction,6,16710952
8,22.1,Vomiting,6,16710952
9,22.1,Abdominal pain upper,6,16710952
10,22.1,Pyrexia,6,16710952
11,22.1,Abdominal pain,6,16710952
12,22.1,Death,5,16710952
13,22.1,Diarrhoea,6,16710952
14,22.1,Neuropathy peripheral,6,16710952
15,22.1,Fatigue,6,16710952
16,22.1,Weight decreased,6,16710952
0,22.0,Goitre,6,16710954
1,22.0,Eczema,6,16710954
2,22.0,Cellulitis,6,16710954
3,22.0,Lumbosacral radiculopathy,6,16710954
4,22.0,Muscular weakness,6,16710954
5,22.0,Palliative care,6,16710954
6,22.0,Dizziness,6,16710954
7,22.0,Hypertension,6,16710954
8,22.0,Proteinuria,6,16710954
9,22.0,Medical procedure,6,16710954
10,22.0,Arachnoiditis,6,16710954
0,22.1,Peripheral motor neuropathy,3,16710956
0,22.1,Lower limb fracture,,16710991
1,22.1,Spinal disorder,,16710991
2,22.1,Hypoaesthesia,,16710991
3,22.1,Faeces soft,,16710991
4,22.1,Neoplasm,,16710991
5,22.1,Nerve compression,,16710991
0,22.1,Metastatic neoplasm,,16710997
0,22.1,Death,,16711002
0,22.1,Blood test abnormal,3,16711005
1,22.1,Device loosening,6,16711005
2,22.1,Tooth abscess,6,16711005
3,22.1,Procedural complication,6,16711005
0,22.1,Paraesthesia,2,16711009
1,22.1,Amenorrhoea,2,16711009
0,22.1,Renal failure,,16711033
0,22.0,Breast cancer,3,16711098
1,22.0,Malignant neoplasm progression,3,16711098
0,22.1,Bone pain,3,16711116
1,22.1,Pneumonia,1,16711116
2,22.1,Lung disorder,6,16711116
3,22.1,Metastases to bone,6,16711116
4,22.1,Prostatic specific antigen increased,6,16711116
0,22.0,Gait disturbance,2,16711135
1,22.0,Rash generalised,2,16711135
2,22.0,Off label use,,16711135
3,22.0,Joint swelling,2,16711135
4,22.0,Dysphagia,2,16711135
5,22.0,Pyrexia,2,16711135
6,22.0,Peripheral swelling,2,16711135
0,22.0,Intentional product misuse,6,16711157
1,22.0,Fulminant type 1 diabetes mellitus,4,16711157
0,22.1,Mycobacterium tuberculosis complex test positive,,16711184
1,22.1,Biopsy bone marrow abnormal,,16711184
2,22.1,Granuloma,,16711184
3,22.1,Pancytopenia,,16711184
4,22.1,Thrombocytopenia,,16711184
5,22.1,Neutropenia,,16711184
6,22.1,Bacteraemia,,16711184
0,22.0,Laryngeal ulceration,6,16711190
1,22.0,Off label use,6,16711190
0,22.0,Eosinophilic pneumonia,1,16711204
0,22.1,Therapy cessation,,16711208
1,22.1,Hysterectomy,,16711208
0,22.1,Unresponsive to stimuli,,16711242
1,22.1,Sepsis,,16711242
0,22.0,Respiratory arrest,5,16711286
1,22.0,Inappropriate schedule of product administration,6,16711286
2,22.0,Pain,6,16711286
0,22.1,Interstitial lung disease,1,16711315
0,22.0,Psychological trauma,6,16711438
1,22.0,Alopecia,2,16711438
0,22.0,Anxiety,6,16711442
1,22.0,Alopecia,2,16711442
2,22.0,Emotional distress,6,16711442
0,22.0,Alopecia,2,16711443
1,22.0,Psychological trauma,6,16711443
0,22.0,Blood creatine phosphokinase increased,6,16711653
0,22.1,Stomatitis,3,16711660
1,22.1,Red blood cell count decreased,3,16711660
2,22.1,Haemoglobin decreased,3,16711660
3,22.1,Fatigue,1,16711660
4,22.1,Bone marrow failure,6,16711660
5,22.1,Haematocrit decreased,3,16711660
6,22.1,Leukopenia,3,16711660
7,22.1,Asthenia,2,16711660
0,22.0,Pyelonephritis,1,16711828
1,22.0,Ureteral stent insertion,6,16711828
0,22.0,No adverse event,6,16711853
0,22.0,Osteonecrosis of jaw,3,16711937
0,22.0,Pneumonia,1,16711990
1,22.0,Product dose omission,6,16711990
0,22.0,Skin discolouration,6,16712022
1,22.0,Diarrhoea,6,16712022
0,22.0,Drug resistance,5,16712029
1,22.0,Malignant neoplasm progression,5,16712029
2,22.0,Acquired gene mutation,5,16712029
0,22.0,Neutropenia,6,16712034
0,22.0,Haemoglobin decreased,3,16712168
0,22.0,Myocarditis,6,16712169
1,22.0,Atrioventricular block complete,6,16712169
0,22.0,Bone pain,3,16712204
1,22.0,Off label use,,16712204
0,22.0,Malaise,6,16712222
1,22.0,Pneumonitis,1,16712222
2,22.0,Off label use,6,16712222
3,22.0,Dyspnoea,1,16712222
4,22.0,Tubulointerstitial nephritis,6,16712222
5,22.0,Fatigue,6,16712222
6,22.0,Renal tubular injury,6,16712222
7,22.0,Blood creatinine increased,3,16712222
0,22.0,Metastases to bone,6,16712239
1,22.0,Paraplegia,6,16712239
2,22.0,Pathological fracture,6,16712239
3,22.0,Hypertension,6,16712239
4,22.0,Osteonecrosis of jaw,6,16712239
5,22.0,Malignant neoplasm of pleura,6,16712239
6,22.0,Metastases to liver,6,16712239
0,22.1,Colitis,1,16712241
1,22.1,General physical health deterioration,1,16712241
2,22.1,Ejection fraction decreased,1,16712241
3,22.1,Diarrhoea,2,16712241
4,22.1,Large intestine infection,1,16712241
0,22.0,Hot flush,6,16712265
1,22.0,Stomatitis,6,16712265
0,22.1,Asthenia,3,16712270
1,22.1,Hordeolum,3,16712270
2,22.1,Feeling abnormal,3,16712270
3,22.1,Nasopharyngitis,3,16712270
4,22.1,Fatigue,3,16712270
5,22.1,Alopecia,3,16712270
6,22.1,Neoplasm progression,6,16712270
7,22.1,Malaise,3,16712270
0,22.0,Tinnitus,6,16712272
1,22.0,Deafness,6,16712272
0,22.0,Pneumonitis,1,16712273
0,22.0,Anaemia,1,16712275
1,22.0,Neutrophil count decreased,1,16712275
0,22.0,Off label use,6,16712279
1,22.0,Hepatitis toxic,3,16712279
0,22.0,Hypotension,6,16712280
0,22.1,Hyperglycaemia,1,16712294
1,22.1,Renal injury,1,16712294
0,22.0,Osteonecrosis of jaw,2,16712335
0,22.0,Death,5,16712338
0,22.1,Fatigue,1,16712340
1,22.1,Decreased appetite,1,16712340
2,22.1,Dyspnoea,1,16712340
3,22.1,Malaise,1,16712340
4,22.1,Supraventricular tachycardia,1,16712340
5,22.1,Arrhythmia,6,16712340
6,22.1,Cardiotoxicity,1,16712340
7,22.1,Ventricular dysfunction,1,16712340
0,22.0,Osteonecrosis of jaw,6,16712357
0,22.0,Acidosis,5,16712361
1,22.0,Pulmonary haemorrhage,5,16712361
0,22.0,Diabetic ketoacidosis,6,16712432
0,22.0,Chest pain,6,16712499
1,22.0,Fatigue,6,16712499
2,22.0,Blood pressure increased,1,16712499
3,22.0,Nausea,1,16712499
4,22.0,Splenic vein thrombosis,6,16712499
5,22.0,Malignant neoplasm progression,6,16712499
6,22.0,Diarrhoea,2,16712499
7,22.0,Taste disorder,6,16712499
8,22.0,Leukocytosis,2,16712499
9,22.0,Hypophagia,1,16712499
10,22.0,Abdominal pain,2,16712499
11,22.0,Vomiting,6,16712499
12,22.0,Decreased appetite,6,16712499
0,22.1,Bone pain,1,16712566
1,22.1,Drug ineffective,6,16712566
0,22.1,Neutropenic sepsis,6,16712567
0,22.1,Drug ineffective,6,16712568
0,22.0,Pruritus,6,16712569
1,22.0,Oral pain,6,16712569
2,22.0,Fatigue,6,16712569
3,22.0,Oropharyngeal pain,6,16712569
0,22.0,Body temperature increased,1,16712570
1,22.0,Asphyxia,1,16712570
2,22.0,Peripheral swelling,1,16712570
3,22.0,Pneumonitis,1,16712570
4,22.0,Fatigue,1,16712570
0,22.0,Oedema peripheral,6,16712572
1,22.0,Weight increased,6,16712572
0,22.1,Drug ineffective,6,16712577
0,22.1,Haematemesis,6,16712580
1,22.1,Acute respiratory failure,5,16712580
0,22.0,Drug intolerance,6,16712600
1,22.0,Alopecia,3,16712600
2,22.0,Metastases to lung,6,16712600
3,22.0,Metastases to liver,6,16712600
4,22.0,Metastases to bone,6,16712600
0,22.0,Hepatitis toxic,3,16712608
0,22.0,Bone marrow failure,2,16712620
0,22.1,Gamma-glutamyltransferase increased,6,16712623
1,22.1,Diarrhoea,1,16712623
2,22.1,Acne,6,16712623
3,22.1,Breast pain,6,16712623
4,22.1,Asthma,3,16712623
5,22.1,Respiratory tract congestion,6,16712623
6,22.1,Fine motor skill dysfunction,6,16712623
7,22.1,Tremor,6,16712623
8,22.1,Nausea,6,16712623
9,22.1,Blood cholesterol increased,6,16712623
10,22.1,Dysphonia,6,16712623
11,22.1,Constipation,2,16712623
12,22.1,Lymphadenopathy,1,16712623
13,22.1,Constipation,1,16712623
14,22.1,Dermatitis allergic,4,16712623
15,22.1,Insomnia,6,16712623
16,22.1,Diarrhoea,1,16712623
17,22.1,Confusional state,6,16712623
18,22.1,Nervousness,3,16712623
19,22.1,Carbohydrate antigen 15-3 increased,6,16712623
20,22.1,Colitis,2,16712623
21,22.1,Dysphonia,1,16712623
22,22.1,Inflammation,6,16712623
23,22.1,Constipation,1,16712623
24,22.1,White blood cell count decreased,6,16712623
25,22.1,Nasopharyngitis,6,16712623
26,22.1,Blood triglycerides increased,6,16712623
27,22.1,Breast mass,6,16712623
28,22.1,Leukaemia,6,16712623
29,22.1,Anisocytosis,6,16712623
30,22.1,Haemoglobin distribution width increased,6,16712623
31,22.1,Blood alkaline phosphatase increased,6,16712623
32,22.1,Diarrhoea,1,16712623
0,22.1,Hydronephrosis,6,16712626
1,22.1,Anxiety,3,16712626
2,22.1,Chest pain,1,16712626
3,22.1,Alopecia,3,16712626
4,22.1,Inappropriate schedule of product administration,6,16712626
5,22.1,Decreased appetite,3,16712626
6,22.1,Haemoglobin decreased,3,16712626
7,22.1,White blood cell count decreased,3,16712626
8,22.1,Epistaxis,1,16712626
9,22.1,Somnolence,3,16712626
10,22.1,Neutrophil count decreased,3,16712626
11,22.1,Breast cancer,6,16712626
12,22.1,Malignant neoplasm progression,6,16712626
13,22.1,Weight decreased,3,16712626
14,22.1,Abdominal discomfort,3,16712626
15,22.1,Electrocardiogram QT prolonged,1,16712626
16,22.1,Rash,3,16712626
17,22.1,Carbohydrate antigen 15-3 increased,3,16712626
18,22.1,Electrolyte imbalance,3,16712626
19,22.1,Pruritus,3,16712626
20,22.1,Asthenia,3,16712626
21,22.1,Nausea,3,16712626
0,22.0,Lung disorder,3,16712628
0,22.0,Pyrexia,6,16712689
1,22.0,Diarrhoea,6,16712689
2,22.0,General physical health deterioration,6,16712689
3,22.0,Colitis,6,16712689
0,22.1,Malignant neoplasm progression,6,16712700
1,22.1,General physical health deterioration,6,16712700
2,22.1,Haemoglobin decreased,1,16712700
3,22.1,Metastases to meninges,6,16712700
4,22.1,Sepsis,5,16712700
5,22.1,Haemoglobin decreased,1,16712700
6,22.1,White blood cell count decreased,5,16712700
7,22.1,Renal failure,5,16712700
8,22.1,Blood creatinine increased,5,16712700
9,22.1,Platelet count decreased,6,16712700
10,22.1,Breast cancer metastatic,6,16712700
0,22.1,Malignant neoplasm progression,5,16712725
1,22.1,Melaena,6,16712725
0,22.1,Dysuria,6,16712727
1,22.1,Urinary retention,6,16712727
0,22.0,Hypertension,1,16712733
1,22.0,Death,5,16712733
0,22.0,Drug ineffective,6,16712739
0,22.0,Autoimmune anaemia,1,16712750
1,22.0,Arthralgia,2,16712750
2,22.0,Myalgia,2,16712750
0,22.0,Pyrexia,4,16712769
1,22.0,Epistaxis,4,16712769
2,22.0,Aspartate aminotransferase increased,4,16712769
3,22.0,Platelet count decreased,3,16712769
4,22.0,Blood bilirubin increased,6,16712769
5,22.0,Lung infection,6,16712769
0,22.0,Hypotension,6,16712825
1,22.0,Cardiac disorder,6,16712825
0,22.1,Erythema,6,16712836
1,22.1,Productive cough,6,16712836
2,22.1,Malignant neoplasm progression,6,16712836
3,22.1,Tracheal mass,2,16712836
4,22.1,Cough,6,16712836
5,22.1,Drug ineffective,1,16712836
6,22.1,Burning sensation,6,16712836
7,22.1,Pyrexia,6,16712836
0,22.1,Medical device removal,1,16712849
1,22.1,Decubitus ulcer,1,16712849
0,22.0,Erysipelas,2,16712869
1,22.0,Arthritis,2,16712869
0,22.0,Pain,1,16712880
1,22.0,Akathisia,1,16712880
0,22.0,Immune-mediated enterocolitis,2,16712895
1,22.0,Diverticulitis,2,16712895
2,22.0,Urinary retention,2,16712895
0,22.0,Pain,1,16712901
1,22.0,Akathisia,1,16712901
0,22.0,Deep vein thrombosis,1,16712919
1,22.0,Ischaemic stroke,1,16712919
0,22.0,Asthenia,3,16712933
1,22.0,Febrile bone marrow aplasia,3,16712933
2,22.0,Diarrhoea,1,16712933
0,22.1,Hyperglycaemia,3,16712937
1,22.1,Back pain,3,16712937
2,22.1,Eye swelling,3,16712937
3,22.1,Dizziness,3,16712937
4,22.1,Agitation,6,16712937
5,22.1,Headache,1,16712937
6,22.1,Anxiety,6,16712937
7,22.1,Infection,1,16712937
8,22.1,Inappropriate schedule of product administration,1,16712937
9,22.1,Tenosynovitis,3,16712937
10,22.1,Joint lock,3,16712937
0,22.1,Vomiting,1,16712965
1,22.1,Abdominal pain upper,1,16712965
2,22.1,Vulvovaginal inflammation,1,16712965
3,22.1,Neuropathy peripheral,3,16712965
4,22.1,Diarrhoea,1,16712965
5,22.1,Dysuria,1,16712965
6,22.1,Rhinorrhoea,1,16712965
7,22.1,Nausea,1,16712965
8,22.1,Asthenia,1,16712965
0,22.0,Hypothyroidism,6,16713004
0,22.0,Anaphylactic shock,1,16713020
0,22.0,Optic disc drusen,6,16713021
1,22.0,Cataract nuclear,6,16713021
2,22.0,Optic ischaemic neuropathy,6,16713021
0,22.0,Off label use,6,16713070
1,22.0,Dehydration,1,16713070
2,22.0,Diarrhoea,1,16713070
3,22.0,Vomiting,1,16713070
0,22.0,Hepatitis toxic,3,16713074
0,22.0,Headache,1,16713081
1,22.0,Paraesthesia,1,16713081
2,22.0,Vomiting,1,16713081
3,22.0,Nausea,1,16713081
4,22.0,Electrocardiogram QT prolonged,1,16713081
5,22.0,Bradycardia,1,16713081
0,22.1,Nausea,2,16713090
1,22.1,Neuralgia,2,16713090
2,22.1,Proteinuria,2,16713090
0,22.0,Chronic kidney disease,6,16713094
0,22.0,Venous thrombosis,1,16713143
0,22.0,Drug eruption,6,16713193
1,22.0,Pain in extremity,2,16713193
2,22.0,Diarrhoea,6,16713193
3,22.0,Bone pain,2,16713193
4,22.0,Electrocardiogram QT prolonged,6,16713193
5,22.0,Skin lesion,6,16713193
6,22.0,Drug intolerance,6,16713193
7,22.0,Headache,2,16713193
0,22.0,Hypokalaemia,1,16713233
1,22.0,Vomiting,1,16713233
0,22.0,Radical prostatectomy,6,16713406
0,22.0,Pyrexia,6,16713464
1,22.0,Renal impairment,2,16713464
0,22.0,Weight increased,6,16713471
0,22.1,Parotitis,3,16713477
1,22.1,Osteonecrosis of jaw,2,16713477
2,22.1,Osteomyelitis,3,16713477
0,22.0,Rash morbilliform,2,16713521
0,22.0,Gastrointestinal disorder,3,16713584
1,22.0,Diarrhoea,3,16713584
0,22.0,Breast cancer,5,16713610
1,22.0,Hepatic failure,5,16713610
0,22.0,Hepatic failure,6,16713663
0,22.0,Hip fracture,6,16713679
0,22.0,Paraesthesia,2,16713769
1,22.0,Amenorrhoea,2,16713769
0,22.0,Device adhesion issue,6,16713798
0,22.0,Vomiting,1,16713822
1,22.0,Febrile neutropenia,1,16713822
2,22.0,Nephrolithiasis,1,16713822
3,22.0,Nausea,1,16713822
4,22.0,General physical health deterioration,1,16713822
0,22.0,Breast cancer,6,16713872
1,22.0,Malignant neoplasm progression,6,16713872
2,22.0,Drug ineffective,6,16713872
0,22.0,Eye pain,2,16713875
1,22.0,Pruritus,6,16713875
2,22.0,Ocular hyperaemia,2,16713875
3,22.0,Diarrhoea,3,16713875
4,22.0,Eating disorder,6,16713875
5,22.0,Dyspnoea,6,16713875
6,22.0,Eye disorder,2,16713875
0,22.0,Product use in unapproved indication,6,16713877
1,22.0,Blood glucose decreased,1,16713877
0,22.0,Sepsis,1,16713879
1,22.0,Hyperlactacidaemia,3,16713879
2,22.0,Lactic acidosis,3,16713879
0,22.0,Overdose,6,16713910
1,22.0,Thrombocytopenia,1,16713910
2,22.0,Anaemia,2,16713910
3,22.0,Neutropenia,1,16713910
4,22.0,Alopecia,1,16713910
0,22.0,Cytopenia,6,16713917
0,22.0,Chest pain,1,16713960
1,22.0,Hypertension,1,16713960
0,22.0,Inappropriate schedule of product administration,6,16713961
1,22.0,Incorrect dose administered,6,16713961
2,22.0,Secondary adrenocortical insufficiency,6,16713961
3,22.0,Adrenocorticotropic hormone deficiency,6,16713961
4,22.0,Hypophysitis,6,16713961
5,22.0,Adrenal insufficiency,6,16713961
0,22.1,Unevaluable event,6,16713964
1,22.1,Adverse event,6,16713964
2,22.1,Taste disorder,3,16713964
3,22.1,Hypersensitivity,3,16713964
4,22.1,Dysuria,6,16713964
5,22.1,Eyelid rash,3,16713964
6,22.1,Dyschezia,3,16713964
7,22.1,Cystitis,2,16713964
8,22.1,Rash,3,16713964
0,22.0,Hypersensitivity,2,16713968
1,22.0,Tachycardia,2,16713968
2,22.0,Acute respiratory failure,2,16713968
3,22.0,Abdominal pain upper,2,16713968
4,22.0,Back pain,2,16713968
0,22.0,Fall,6,16714030
1,22.0,Fracture,3,16714030
0,22.1,Intentional product use issue,6,16714073
1,22.1,Hospitalisation,6,16714073
0,22.0,Fatigue,3,16714121
1,22.0,Appetite disorder,3,16714121
2,22.0,Hot flush,3,16714121
3,22.0,Peripheral swelling,3,16714121
4,22.0,Neuralgia,3,16714121
5,22.0,Insomnia,3,16714121
0,22.1,Anaemia,6,16714156
1,22.1,Product use in unapproved indication,6,16714156
0,22.1,Anaemia,6,16714157
1,22.1,Product use in unapproved indication,6,16714157
0,22.0,Rectal prolapse,6,16714168
0,22.0,Rheumatic disorder,3,16714189
0,22.0,Gastrointestinal haemorrhage,5,16714197
0,22.0,Arthralgia,6,16714198
1,22.0,Thrombocytopenia,6,16714198
2,22.0,Oedema peripheral,6,16714198
3,22.0,Neuropathy peripheral,6,16714198
4,22.0,Fatigue,6,16714198
5,22.0,Diarrhoea,6,16714198
6,22.0,Blood creatinine increased,6,16714198
7,22.0,Anaemia,6,16714198
8,22.0,Aspartate aminotransferase increased,6,16714198
9,22.0,Infection,6,16714198
10,22.0,Nausea,6,16714198
11,22.0,Thrombosis,6,16714198
12,22.0,Alanine aminotransferase increased,6,16714198
13,22.0,Blood bilirubin increased,6,16714198
14,22.0,Decreased appetite,6,16714198
15,22.0,Rash,6,16714198
16,22.0,Haemorrhage,6,16714198
17,22.0,Lymphopenia,6,16714198
18,22.0,Blood creatine phosphokinase increased,6,16714198
19,22.0,Pyrexia,6,16714198
20,22.0,Leukopenia,6,16714198
0,22.0,Neoplasm malignant,5,16714201
0,22.0,Abdominal pain,1,16714264
1,22.0,Nausea,1,16714264
2,22.0,Hypotension,1,16714264
3,22.0,Hyperhidrosis,1,16714264
4,22.0,Dyspnoea,1,16714264
5,22.0,Colitis,1,16714264
6,22.0,Diarrhoea,1,16714264
7,22.0,Acute kidney injury,6,16714264
8,22.0,Dizziness,1,16714264
0,22.0,General physical health deterioration,6,16714276
1,22.0,Renal failure,3,16714276
2,22.0,Metastases to spine,3,16714276
3,22.0,Urine output decreased,3,16714276
4,22.0,Cardio-respiratory arrest,5,16714276
5,22.0,Eating disorder,3,16714276
6,22.0,Diarrhoea,1,16714276
0,22.0,Pneumothorax,6,16714280
1,22.0,Subcutaneous emphysema,6,16714280
0,22.0,Fatigue,6,16714417
1,22.0,Hepatotoxicity,6,16714417
2,22.0,Anaemia,6,16714417
3,22.0,White blood cell count decreased,6,16714417
4,22.0,Death,5,16714417
5,22.0,Nausea,6,16714417
6,22.0,Diarrhoea,6,16714417
7,22.0,Stomatitis,6,16714417
8,22.0,Hypersensitivity,6,16714417
9,22.0,Phlebitis,6,16714417
10,22.0,Neuropathy peripheral,6,16714417
11,22.0,Vomiting,6,16714417
12,22.0,Nephropathy toxic,6,16714417
13,22.0,Metabolic disorder,6,16714417
14,22.0,Neutropenia,6,16714417
15,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16714417
16,22.0,Thrombocytopenia,6,16714417
0,22.0,Diarrhoea,1,16714472
1,22.0,Dehydration,1,16714472
0,22.0,Thrombocytopenia,6,16714501
1,22.0,Thrombotic microangiopathy,6,16714501
0,22.0,Anaemia,6,16714608
1,22.0,Pneumothorax,6,16714608
2,22.0,Hypersensitivity,6,16714608
0,22.1,Pain,6,16714671
1,22.1,Pulmonary embolism,6,16714671
2,22.1,Nasopharyngitis,6,16714671
0,22.1,Pleural effusion,6,16714693
1,22.1,Weight decreased,6,16714693
2,22.1,Malaise,1,16714693
3,22.1,Pneumonia,1,16714693
4,22.1,Pyrexia,6,16714693
0,22.0,Localised infection,1,16714734
1,22.0,Lower respiratory tract infection,1,16714734
2,22.0,Musculoskeletal pain,1,16714734
0,22.0,Paraesthesia,2,16714781
1,22.0,Dizziness,1,16714781
2,22.0,Erythema,2,16714781
3,22.0,Hypersensitivity,1,16714781
0,22.0,Cardiac failure,2,16714782
1,22.0,Pleural effusion,2,16714782
2,22.0,Congestive cardiomyopathy,2,16714782
0,22.1,Anaemia,6,16714789
1,22.1,Product use in unapproved indication,6,16714789
2,22.1,Fall,6,16714789
3,22.1,Death,5,16714789
4,22.1,Syncope,6,16714789
5,22.1,Catheter site haemorrhage,6,16714789
6,22.1,Asthenia,6,16714789
0,22.0,Off label use,6,16714820
1,22.0,Dementia,1,16714820
0,22.1,Fall,2,16714827
1,22.1,Arthritis infective,1,16714827
0,22.1,Product size issue,6,16714828
1,22.1,Product use complaint,6,16714828
2,22.1,Decreased appetite,6,16714828
3,22.1,Pruritus,3,16714828
4,22.1,Fatigue,6,16714828
5,22.1,Malignant neoplasm progression,6,16714828
6,22.1,Skin discolouration,6,16714828
7,22.1,Asthenia,6,16714828
8,22.1,Therapy cessation,6,16714828
9,22.1,Insomnia,6,16714828
10,22.1,Choking,1,16714828
11,22.1,Nail discolouration,6,16714828
0,22.1,Gastrointestinal ulcer,6,16714831
1,22.1,Weight decreased,6,16714831
2,22.1,Urinary tract infection,6,16714831
3,22.1,Constipation,6,16714831
0,22.0,Death,5,16714858
0,22.0,Death,5,16714890
0,22.0,Neuropathy peripheral,6,16714910
0,22.0,Lymphadenopathy,6,16714948
1,22.0,Hot flush,6,16714948
2,22.0,Condition aggravated,6,16714948
3,22.0,Oedema peripheral,6,16714948
4,22.0,Prostatic specific antigen increased,6,16714948
0,22.1,Mouth haemorrhage,6,16714955
1,22.1,Diarrhoea,6,16714955
2,22.1,Eczema,6,16714955
3,22.1,Weight decreased,6,16714955
4,22.1,Asthenia,6,16714955
5,22.1,Rash pruritic,6,16714955
6,22.1,Peripheral swelling,6,16714955
7,22.1,Fatigue,6,16714955
0,22.0,Osteolysis,6,16714989
1,22.0,Metastases to bone,6,16714989
2,22.0,Pleural thickening,6,16714989
3,22.0,Breast injury,6,16714989
4,22.0,Dyspnoea,6,16714989
5,22.0,Febrile neutropenia,6,16714989
6,22.0,Neutropenia,6,16714989
7,22.0,Pleural effusion,6,16714989
0,22.0,Systemic inflammatory response syndrome,3,16715015
0,22.0,Malignant neoplasm progression,6,16715017
0,22.0,Paraesthesia,1,16715024
1,22.0,Erythema,1,16715024
2,22.0,Hypersensitivity,1,16715024
0,22.0,Prescribed underdose,6,16715056
1,22.0,Hypokalaemia,1,16715056
2,22.0,Off label use,6,16715056
0,22.0,Neoplasm progression,6,16715064
0,22.0,Neutropenia,6,16715072
0,22.0,Pruritus,6,16715162
0,22.1,Suicidal ideation,6,16715286
1,22.1,Muscle spasms,6,16715286
0,22.0,Hypersensitivity,1,16715310
1,22.0,Kounis syndrome,4,16715310
0,22.0,Neoplasm progression,6,16715348
0,22.0,Product dose omission,6,16715350
1,22.0,Malaise,6,16715350
0,22.1,Neoplasm progression,6,16715356
1,22.1,Oral contusion,3,16715356
0,22.1,Abdominal pain,6,16715359
1,22.1,Mood altered,6,16715359
2,22.1,Nausea,6,16715359
3,22.1,Ascites,6,16715359
4,22.1,Abdominal discomfort,6,16715359
5,22.1,Abdominal pain upper,6,16715359
6,22.1,Asthenia,3,16715359
7,22.1,Vision blurred,6,16715359
8,22.1,Intestinal haemorrhage,6,16715359
9,22.1,Vomiting,6,16715359
10,22.1,Alopecia,6,16715359
11,22.1,Muscle spasms,6,16715359
12,22.1,Bone pain,6,16715359
13,22.1,Mobility decreased,6,16715359
0,22.0,Neoplasm progression,6,16715361
0,22.0,Neoplasm progression,6,16715371
0,22.0,Neoplasm progression,6,16715372
0,22.0,Taste disorder,6,16715376
1,22.0,Fatigue,6,16715376
0,22.0,Hair colour changes,6,16715381
1,22.0,Diarrhoea,1,16715381
0,22.1,Fatigue,,16715390
1,22.1,Vomiting,,16715390
2,22.1,Nausea,,16715390
0,22.1,Diverticulum,1,16715443
1,22.1,Abdominal pain,1,16715443
0,22.0,Dysphonia,6,16715451
1,22.0,Marasmus,6,16715451
2,22.0,Blood albumin abnormal,6,16715451
3,22.0,Pain,6,16715451
4,22.0,Chest discomfort,6,16715451
5,22.0,Death,5,16715451
6,22.0,Chest pain,6,16715451
7,22.0,Abdominal distension,6,16715451
0,22.0,Leg amputation,,16715466
0,22.0,Fibrosis,,16715481
1,22.0,Pneumonitis,,16715481
0,22.0,Death,5,16715518
0,22.0,Deep vein thrombosis,2,16715525
0,22.0,Death,5,16715527
0,22.0,Second primary malignancy,6,16715529
1,22.0,Brain neoplasm,6,16715529
0,22.1,Syncope,1,16715547
0,22.1,Malaise,6,16715596
1,22.1,Pain,3,16715596
2,22.1,Weight decreased,6,16715596
3,22.1,Nausea,6,16715596
4,22.1,Discomfort,3,16715596
5,22.1,Influenza,6,16715596
0,22.0,Renal disorder,3,16715617
1,22.0,Cardiac tamponade,6,16715617
0,22.1,Hospice care,,16715633
0,22.0,Bone marrow failure,6,16715669
0,22.0,Skin disorder,1,16715674
1,22.0,Hepatic function abnormal,6,16715674
0,22.0,Headache,6,16715720
1,22.0,Dizziness,6,16715720
2,22.0,Nausea,6,16715720
3,22.0,Spinal pain,6,16715720
4,22.0,Asthenia,6,16715720
5,22.0,Muscular weakness,6,16715720
0,22.0,White blood cell count abnormal,6,16715733
0,22.1,Death,5,16715799
0,22.0,Second primary malignancy,5,16715808
1,22.0,Acute myeloid leukaemia,5,16715808
2,22.0,Myasthenia gravis,5,16715808
3,22.0,Myelodysplastic syndrome,5,16715808
4,22.0,Infection,5,16715808
0,22.0,Death,5,16715810
0,22.1,Pericardial effusion,,16715813
0,22.0,Death,5,16715814
0,22.0,Death,5,16715816
0,22.0,Sudden death,5,16715826
0,22.0,Drug ineffective,6,16715832
1,22.0,Hyperaesthesia,2,16715832
2,22.0,Weight decreased,6,16715832
3,22.0,Decreased appetite,6,16715832
4,22.0,Abdominal pain upper,2,16715832
0,22.0,Seizure,2,16715834
1,22.0,Vomiting,2,16715834
2,22.0,Asthenia,2,16715834
3,22.0,Headache,2,16715834
4,22.0,Blood pressure increased,2,16715834
5,22.0,Haemorrhagic stroke,2,16715834
6,22.0,Blindness,2,16715834
7,22.0,Pain in extremity,2,16715834
0,22.1,Neutrophil count decreased,6,16715849
1,22.1,Full blood count abnormal,1,16715849
2,22.1,Red blood cell count decreased,6,16715849
0,22.1,Loss of consciousness,6,16715864
1,22.1,Drug hypersensitivity,6,16715864
2,22.1,Cortisol decreased,6,16715864
3,22.1,Foot deformity,6,16715864
4,22.1,Hunger,6,16715864
5,22.1,Anger,6,16715864
6,22.1,Pain in extremity,6,16715864
7,22.1,Fall,6,16715864
8,22.1,Malaise,6,16715864
9,22.1,Feeding disorder,6,16715864
10,22.1,Loss of personal independence in daily activities,6,16715864
11,22.1,Discharge,6,16715864
12,22.1,Adrenal gland injury,6,16715864
13,22.1,Mental disorder,6,16715864
14,22.1,Dizziness,6,16715864
15,22.1,Blood pressure decreased,6,16715864
16,22.1,Peripheral swelling,6,16715864
17,22.1,Diarrhoea,6,16715864
18,22.1,Neuropathy peripheral,6,16715864
19,22.1,Hypothalamo-pituitary disorder,6,16715864
20,22.1,Musculoskeletal chest pain,6,16715864
21,22.1,Neoplasm progression,6,16715864
22,22.1,Infection,6,16715864
23,22.1,Blood pressure fluctuation,6,16715864
0,22.1,Pneumonia,,16715871
0,22.0,No adverse event,6,16715878
0,22.1,Urinary straining,6,16715943
1,22.1,White blood cell count decreased,6,16715943
2,22.1,Weight decreased,2,16715943
3,22.1,Chronic kidney disease,6,16715943
4,22.1,Decreased appetite,6,16715943
5,22.1,Diarrhoea,1,16715943
6,22.1,Vomiting,1,16715943
7,22.1,Renal impairment,6,16715943
8,22.1,Platelet count decreased,6,16715943
9,22.1,Fatigue,3,16715943
10,22.1,Asthenia,6,16715943
0,22.1,Temperature regulation disorder,6,16715954
1,22.1,Blood lactate dehydrogenase increased,6,16715954
2,22.1,Pain,6,16715954
3,22.1,Vulvovaginal candidiasis,6,16715954
4,22.1,Oesophageal candidiasis,6,16715954
5,22.1,Skin haemorrhage,6,16715954
6,22.1,Superinfection,6,16715954
7,22.1,Hypoalbuminaemia,6,16715954
8,22.1,Spondylolisthesis,6,16715954
9,22.1,Vitamin D deficiency,6,16715954
10,22.1,Temperature regulation disorder,6,16715954
11,22.1,Dysphagia,6,16715954
12,22.1,Anaemia,2,16715954
13,22.1,Malnutrition,6,16715954
14,22.1,Leukopenia,6,16715954
15,22.1,Pyrexia,1,16715954
16,22.1,Prerenal failure,2,16715954
17,22.1,Toxic epidermal necrolysis,2,16715954
18,22.1,Pancytopenia,6,16715954
19,22.1,Stevens-Johnson syndrome,2,16715954
20,22.1,Back pain,3,16715954
21,22.1,Fluid overload,6,16715954
22,22.1,Primary hypothyroidism,6,16715954
23,22.1,Osteoarthritis,6,16715954
24,22.1,Electrocardiogram abnormal,6,16715954
25,22.1,Hypertension,6,16715954
26,22.1,Product use in unapproved indication,6,16715954
27,22.1,Dermatitis bullous,6,16715954
28,22.1,Lymphadenopathy,6,16715954
29,22.1,Oral candidiasis,6,16715954
30,22.1,Staphylococcal bacteraemia,6,16715954
31,22.1,Oedema,6,16715954
32,22.1,Rash,2,16715954
33,22.1,Scar,6,16715954
34,22.1,Hypokalaemia,6,16715954
35,22.1,Psychomotor disadaptation syndrome,6,16715954
36,22.1,Neutropenia,6,16715954
37,22.1,Lymphopenia,6,16715954
38,22.1,Erythema multiforme,6,16715954
0,22.0,Hip fracture,6,16715980
0,22.0,Rash,1,16716020
1,22.0,Photosensitivity reaction,6,16716020
0,22.0,Hepatocellular injury,3,16716024
0,22.0,Metastases to the mediastinum,6,16716030
1,22.0,Metastases to lung,6,16716030
2,22.0,Malignant neoplasm progression,6,16716030
3,22.0,Breast cancer metastatic,6,16716030
0,22.1,Haemoptysis,5,16716105
1,22.1,Malignant neoplasm progression,5,16716105
0,22.0,Pericardial effusion,6,16716131
1,22.0,Axillary pain,6,16716131
0,22.0,Chronic myeloid leukaemia,5,16716148
1,22.0,Haemorrhage,5,16716148
0,22.1,Alopecia,6,16716149
1,22.1,Diarrhoea,6,16716149
2,22.1,Dyspnoea,6,16716149
3,22.1,Oedema peripheral,6,16716149
4,22.1,Decreased appetite,6,16716149
5,22.1,Fatigue,6,16716149
6,22.1,Bone lesion,6,16716149
7,22.1,Central nervous system lesion,6,16716149
8,22.1,Metastases to liver,1,16716149
9,22.1,Metastases to lung,1,16716149
10,22.1,Metastases to central nervous system,6,16716149
11,22.1,Right ventricular dysfunction,6,16716149
12,22.1,Metastases to nervous system,1,16716149
13,22.1,Osteolysis,6,16716149
14,22.1,Metastases to bone,1,16716149
15,22.1,Pulmonary embolism,6,16716149
0,22.0,Accidental exposure to product,6,16716178
1,22.0,Product dose omission,6,16716178
2,22.0,Device defective,6,16716178
0,22.0,Small cell lung cancer,3,16716187
1,22.0,Second primary malignancy,3,16716187
0,22.0,White blood cell count decreased,6,16716193
1,22.0,Haemoglobin decreased,6,16716193
2,22.0,Spinal fracture,6,16716193
3,22.0,Dyspnoea exertional,6,16716193
4,22.0,Haematocrit decreased,6,16716193
5,22.0,Febrile neutropenia,6,16716193
0,22.0,Death,5,16716200
0,22.0,Abdominal infection,6,16716204
1,22.0,Back pain,6,16716204
2,22.0,Breast pain,6,16716204
3,22.0,Hypocalcaemia,6,16716204
4,22.0,Hypokalaemia,6,16716204
5,22.0,Menstruation irregular,6,16716204
6,22.0,Muscular weakness,6,16716204
7,22.0,Pruritus,6,16716204
8,22.0,Upper respiratory tract infection,6,16716204
9,22.0,Acute kidney injury,6,16716204
10,22.0,Cholecystitis,6,16716204
11,22.0,Infective myositis,6,16716204
12,22.0,Joint effusion,6,16716204
13,22.0,Radiation skin injury,6,16716204
14,22.0,Reproductive tract disorder,6,16716204
15,22.0,Weight decreased,6,16716204
16,22.0,Bronchitis,6,16716204
17,22.0,Gamma-glutamyltransferase increased,6,16716204
18,22.0,Hypoalbuminaemia,6,16716204
19,22.0,Hypophosphataemia,6,16716204
20,22.0,Neck pain,6,16716204
21,22.0,Pleural effusion,6,16716204
22,22.0,Sinusitis,6,16716204
23,22.0,Skin disorder,6,16716204
24,22.0,Vaginal perforation,6,16716204
25,22.0,Alkalosis,6,16716204
26,22.0,Breast disorder,6,16716204
27,22.0,Depression,6,16716204
28,22.0,Infestation,6,16716204
29,22.0,Insomnia,6,16716204
30,22.0,Myositis,6,16716204
31,22.0,Nail infection,6,16716204
32,22.0,Vaginal haemorrhage,6,16716204
33,22.0,Wound dehiscence,6,16716204
34,22.0,Hypotension,6,16716204
35,22.0,Kidney infection,6,16716204
36,22.0,Lipase increased,6,16716204
37,22.0,Leukaemia,6,16716204
38,22.0,Skin infection,6,16716204
39,22.0,Anxiety,6,16716204
40,22.0,Arthritis,6,16716204
41,22.0,Nervous system disorder,6,16716204
42,22.0,Pharyngitis,6,16716204
43,22.0,Renal disorder,6,16716204
44,22.0,Seroma,6,16716204
45,22.0,Trismus,6,16716204
46,22.0,Urinary tract pain,6,16716204
47,22.0,Blood creatinine increased,6,16716204
48,22.0,Device related infection,6,16716204
49,22.0,Dizziness,6,16716204
50,22.0,Enterocolitis infectious,6,16716204
51,22.0,Epistaxis,6,16716204
52,22.0,International normalised ratio increased,6,16716204
53,22.0,Pharyngeal inflammation,6,16716204
54,22.0,Presyncope,6,16716204
55,22.0,Troponin I increased,6,16716204
56,22.0,Hyponatraemia,6,16716204
57,22.0,Cystitis noninfective,6,16716204
58,22.0,Decreased appetite,6,16716204
59,22.0,Hot flush,6,16716204
60,22.0,Hyperglycaemia,6,16716204
61,22.0,Infection,6,16716204
62,22.0,Otitis media,6,16716204
63,22.0,Respiratory failure,6,16716204
64,22.0,Second primary malignancy,6,16716204
65,22.0,Uterine haemorrhage,6,16716204
0,22.0,Death,5,16716207
0,22.0,Second primary malignancy,5,16716208
1,22.0,Neutrophil count decreased,5,16716208
0,22.0,Non-small cell lung cancer,6,16716234
0,22.1,Malaise,,16716248
1,22.1,Pyrexia,,16716248
2,22.1,Conjunctivitis,,16716248
3,22.1,Stevens-Johnson syndrome,,16716248
0,22.0,Autoimmune haemolytic anaemia,1,16716268
1,22.0,Tremor,1,16716268
2,22.0,Urinary tract infection,1,16716268
0,22.0,Fatigue,6,16716269
1,22.0,Death,5,16716269
0,22.0,Dysstasia,1,16716279
1,22.0,Gait inability,1,16716279
2,22.0,Femoral neck fracture,1,16716279
0,22.1,Antinuclear antibody positive,6,16716314
1,22.1,Duodenitis,2,16716314
2,22.1,Dehydration,2,16716314
0,22.0,Dyspnoea paroxysmal nocturnal,6,16716348
0,22.1,Thermal burn,3,16716349
1,22.1,Product dose omission,6,16716349
2,22.1,Lip dry,3,16716349
3,22.1,Peripheral swelling,1,16716349
4,22.1,Constipation,6,16716349
5,22.1,Dementia,3,16716349
0,22.0,Pyrexia,3,16716390
0,22.1,Death,5,16716450
1,22.1,Immune-mediated enterocolitis,1,16716450
2,22.1,Large intestine perforation,1,16716450
3,22.1,Interstitial lung disease,1,16716450
0,22.0,Death,5,16716458
0,22.0,Hypophagia,3,16716459
1,22.0,Death,5,16716459
2,22.0,Decubitus ulcer,3,16716459
3,22.0,Immobile,3,16716459
0,22.0,Loss of consciousness,6,16716461
1,22.0,Malaise,3,16716461
2,22.0,Nausea,3,16716461
3,22.0,Decreased appetite,3,16716461
4,22.0,Synovial cyst,6,16716461
5,22.0,Peripheral swelling,6,16716461
6,22.0,Pain,3,16716461
7,22.0,Back pain,3,16716461
8,22.0,Vomiting,3,16716461
9,22.0,Skin discolouration,6,16716461
10,22.0,Neoplasm progression,6,16716461
11,22.0,Peripheral swelling,3,16716461
12,22.0,Fatigue,3,16716461
13,22.0,Gait disturbance,3,16716461
14,22.0,Bone pain,6,16716461
15,22.0,Headache,6,16716461
16,22.0,Pain in extremity,3,16716461
0,22.0,Localised infection,2,16716466
1,22.0,Red blood cell count decreased,2,16716466
0,22.0,Acute myeloid leukaemia,5,16716471
1,22.0,Second primary malignancy,5,16716471
0,22.0,Decubitus ulcer,1,16716472
0,22.0,Death,5,16716489
0,22.0,Second primary malignancy,5,16716492
0,22.0,Neoplasm progression,2,16716501
1,22.0,Platelet count decreased,2,16716501
2,22.0,Cytopenia,2,16716501
3,22.0,Haemoglobin decreased,2,16716501
4,22.0,Blood lactate dehydrogenase increased,2,16716501
0,22.0,Autoimmune myocarditis,5,16716506
1,22.0,Cardiac failure congestive,5,16716506
0,22.1,Alanine aminotransferase increased,6,16716543
1,22.1,Aspartate aminotransferase increased,6,16716543
2,22.1,Red cell distribution width increased,6,16716543
3,22.1,Leukopenia,3,16716543
4,22.1,Deep vein thrombosis,1,16716543
5,22.1,Glomerular filtration rate decreased,6,16716543
6,22.1,Gamma-glutamyltransferase increased,6,16716543
0,22.0,Weight increased,6,16716545
1,22.0,Disease recurrence,6,16716545
2,22.0,Sudden hearing loss,3,16716545
3,22.0,Rash,6,16716545
4,22.0,Hyperhidrosis,6,16716545
5,22.0,Hyperhidrosis,6,16716545
6,22.0,Paraesthesia,6,16716545
7,22.0,Alopecia,6,16716545
8,22.0,Off label use,6,16716545
0,22.1,Fatigue,3,16716547
1,22.1,Bone marrow failure,6,16716547
2,22.1,Neoplasm progression,6,16716547
0,22.1,Neoplasm progression,5,16716555
1,22.1,Haemoglobin decreased,6,16716555
2,22.1,Dyspnoea,6,16716555
3,22.1,Weight decreased,6,16716555
4,22.1,Product use in unapproved indication,6,16716555
5,22.1,Off label use,6,16716555
0,22.0,Onychalgia,3,16716556
1,22.0,Haematemesis,1,16716556
2,22.0,Malaise,1,16716556
3,22.0,Candida infection,1,16716556
4,22.0,Alopecia,1,16716556
5,22.0,Nausea,3,16716556
6,22.0,Hypernatraemia,1,16716556
7,22.0,Fatigue,3,16716556
8,22.0,Decreased appetite,3,16716556
9,22.0,Neutropenia,1,16716556
10,22.0,Pain in jaw,1,16716556
0,22.0,Hypokalaemia,6,16716559
1,22.0,Leukopenia,6,16716559
2,22.0,Product dose omission,6,16716559
3,22.0,Alopecia,6,16716559
4,22.0,Contusion,6,16716559
5,22.0,Thrombocytopenia,6,16716559
6,22.0,Night sweats,6,16716559
7,22.0,Pyrexia,6,16716559
8,22.0,Nausea,6,16716559
0,22.0,Death,5,16716561
0,22.0,Second primary malignancy,6,16716590
1,22.0,Acute lymphocytic leukaemia,6,16716590
2,22.0,Breast cancer recurrent,6,16716590
3,22.0,Malignant neoplasm progression,6,16716590
0,22.1,Thrombosis,6,16716724
1,22.1,Neoplasm progression,6,16716724
0,22.0,Neoplasm progression,6,16716732
1,22.0,Febrile neutropenia,1,16716732
2,22.0,Granulocytopenia,1,16716732
0,22.1,Upper gastrointestinal haemorrhage,1,16716752
0,22.0,Blood test abnormal,6,16716767
1,22.0,Onychomadesis,3,16716767
0,22.0,Malaise,1,16716796
1,22.0,Erythema,1,16716796
2,22.0,Dyspnoea,1,16716796
3,22.0,Back pain,1,16716796
0,22.0,Off label use,1,16716832
0,22.1,Pulmonary fibrosis,6,16716968
1,22.1,Chest pain,6,16716968
2,22.1,Bronchioloalveolar carcinoma,6,16716968
0,22.0,Productive cough,6,16716974
1,22.0,Pyrexia,1,16716974
2,22.0,Thrombocytopenia,1,16716974
3,22.0,Leukopenia,1,16716974
4,22.0,Cough,1,16716974
0,22.0,Hyperlactacidaemia,3,16716983
1,22.0,Lactic acidosis,3,16716983
2,22.0,Sepsis,1,16716983
0,22.0,Myelodysplastic syndrome,3,16716985
0,22.0,Death,5,16717054
0,22.0,Thrombocytopenia,2,16717063
0,22.0,Carcinoembryonic antigen increased,6,16717064
1,22.0,Off label use,6,16717064
0,22.0,Penile cancer,5,16717065
1,22.0,Off label use,6,16717065
0,22.0,Hypertension,1,16717069
1,22.0,Chills,1,16717069
2,22.0,Malaise,1,16717069
3,22.0,Headache,1,16717069
4,22.0,Vertigo,1,16717069
5,22.0,Oxygen saturation decreased,1,16717069
0,22.0,Cachexia,5,16717073
1,22.0,Off label use,6,16717073
0,22.0,Chills,6,16717094
1,22.0,Blister,3,16717094
2,22.0,Fatigue,6,16717094
0,22.0,Nausea,1,16717121
1,22.0,Headache,1,16717121
2,22.0,Diarrhoea,1,16717121
3,22.0,Vomiting,1,16717121
0,22.0,Neutropenia,1,16717147
1,22.0,Abdominal pain,1,16717147
0,22.0,Fatigue,6,16717192
1,22.0,Gastrointestinal disorder,6,16717192
0,22.1,Malaise,1,16717196
1,22.1,Enteritis,1,16717196
2,22.1,Nausea,6,16717196
3,22.1,Vomiting,6,16717196
0,22.0,Hair texture abnormal,3,16717197
1,22.0,Madarosis,1,16717197
2,22.0,Alopecia,3,16717197
3,22.0,Hair colour changes,3,16717197
4,22.0,Hair disorder,3,16717197
0,22.0,Fatigue,6,16717199
0,22.1,Insomnia,6,16717210
1,22.1,Neck pain,6,16717210
2,22.1,Pruritus,6,16717210
3,22.1,Fatigue,6,16717210
4,22.1,White blood cell count decreased,6,16717210
5,22.1,Diarrhoea,6,16717210
0,22.0,Malaise,6,16717212
0,22.0,Blood urine present,6,16717253
0,22.0,Transient ischaemic attack,1,16717304
0,22.0,Death,5,16717324
0,22.0,Malignant neoplasm progression,6,16717336
1,22.0,Malignant peritoneal neoplasm,6,16717336
2,22.0,Product use in unapproved indication,6,16717336
3,22.0,Ovarian epithelial cancer,6,16717336
4,22.0,Rash,6,16717336
5,22.0,Generalised oedema,6,16717336
0,22.1,Hyponatraemia,1,16717363
1,22.1,Abdominal pain,1,16717363
2,22.1,Blood bilirubin increased,3,16717363
3,22.1,Nausea,1,16717363
4,22.1,Dehydration,1,16717363
5,22.1,Fatigue,1,16717363
0,22.0,Hypomagnesaemia,1,16717380
0,22.1,Vomiting,,16717387
1,22.1,Pain in extremity,,16717387
2,22.1,Dyschezia,2,16717387
3,22.1,Nephritis,2,16717387
4,22.1,Somnolence,,16717387
5,22.1,Feeding disorder,,16717387
6,22.1,Haemorrhage,2,16717387
7,22.1,Drug ineffective,,16717387
8,22.1,Drug hypersensitivity,,16717387
9,22.1,Abdominal distension,2,16717387
10,22.1,Fatigue,,16717387
0,22.0,Periorbital oedema,1,16717412
1,22.0,Infusion site pain,1,16717412
2,22.0,Erythema,1,16717412
3,22.0,Feeling hot,1,16717412
4,22.0,Pruritus,1,16717412
5,22.0,Swelling face,1,16717412
6,22.0,Infusion site erythema,1,16717412
7,22.0,Infusion site urticaria,1,16717412
8,22.0,Flushing,1,16717412
9,22.0,Urticaria,1,16717412
0,22.0,Dehydration,3,16717508
1,22.0,Disorientation,3,16717508
2,22.0,Malignant neoplasm progression,3,16717508
3,22.0,Musculoskeletal stiffness,3,16717508
4,22.0,Fatigue,3,16717508
5,22.0,Middle insomnia,3,16717508
6,22.0,Dysphonia,3,16717508
7,22.0,Feeling abnormal,3,16717508
8,22.0,Dizziness,3,16717508
0,22.0,Blood phosphorus increased,6,16717517
1,22.0,Blood uric acid increased,6,16717517
2,22.0,Tumour lysis syndrome,5,16717517
3,22.0,Blood potassium increased,6,16717517
4,22.0,Blood creatinine increased,6,16717517
5,22.0,Blood lactate dehydrogenase increased,6,16717517
0,22.0,Tumour lysis syndrome,5,16717519
1,22.0,Dyspnoea,6,16717519
2,22.0,Hypotension,6,16717519
3,22.0,Blood uric acid abnormal,5,16717519
4,22.0,Blood urea abnormal,5,16717519
5,22.0,Blood potassium abnormal,5,16717519
6,22.0,Malaise,6,16717519
7,22.0,Blood phosphorus abnormal,5,16717519
8,22.0,Acute kidney injury,5,16717519
9,22.0,Somnolence,6,16717519
10,22.0,Blood creatinine abnormal,5,16717519
0,22.0,Alopecia,2,16717520
0,22.1,Emotional distress,6,16717527
1,22.1,Psychological trauma,6,16717527
2,22.1,Alopecia,2,16717527
3,22.1,Impaired quality of life,6,16717527
4,22.1,Anxiety,6,16717527
5,22.1,Pain,6,16717527
0,22.0,Alopecia,2,16717530
0,22.0,General physical health deterioration,6,16717771
1,22.0,Death,5,16717771
0,22.1,Drug-induced liver injury,1,16717779
0,22.0,Acute myeloid leukaemia,3,16717802
1,22.0,Second primary malignancy,3,16717802
0,22.0,Acute lymphocytic leukaemia,6,16717803
1,22.0,Second primary malignancy,6,16717803
0,22.0,Product use in unapproved indication,6,16717872
1,22.0,Movement disorder,6,16717872
2,22.0,Malignant neoplasm progression,6,16717872
3,22.0,Asthenia,6,16717872
4,22.0,General physical health deterioration,6,16717872
0,22.0,Dehydration,3,16717924
1,22.0,Weight decreased,2,16717924
2,22.0,Fatigue,3,16717924
3,22.0,Sinusitis bacterial,6,16717924
4,22.0,Off label use,6,16717924
5,22.0,Death,5,16717924
6,22.0,Pulmonary oedema,6,16717924
7,22.0,Platelet count decreased,6,16717924
8,22.0,Decreased appetite,2,16717924
9,22.0,Haemoglobin decreased,6,16717924
10,22.0,Tremor,6,16717924
0,22.0,Lymph gland infection,6,16717925
0,22.0,Malignant neoplasm progression,6,16717996
1,22.0,Anaemia,6,16717996
2,22.0,Acute kidney injury,6,16717996
0,22.0,Cerebral infarction,3,16718017
1,22.0,Cardiac disorder,3,16718017
2,22.0,Dementia,3,16718017
0,22.0,Malignant neoplasm progression,3,16718030
1,22.0,Death,5,16718030
2,22.0,Breast cancer metastatic,3,16718030
0,22.0,Large intestinal ulcer,1,16718071
0,22.0,Febrile neutropenia,1,16718074
0,22.0,Renal vein thrombosis,6,16718174
1,22.0,Interstitial lung disease,6,16718174
2,22.0,Malignant neoplasm progression,5,16718174
0,22.0,Myasthenia gravis,5,16718182
1,22.0,Myocarditis,5,16718182
0,22.0,Malignant neoplasm progression,6,16718271
0,22.1,Seizure,3,16718314
1,22.1,Choking,3,16718314
2,22.1,Cerebral haemorrhage,5,16718314
3,22.1,Circulatory collapse,3,16718314
0,22.0,Death,5,16718315
1,22.0,Intentional product use issue,6,16718315
0,22.0,Abdominal pain,4,16718331
1,22.0,Anaemia,4,16718331
2,22.0,Abdominal pain upper,6,16718331
0,22.0,Intentional product use issue,6,16718352
1,22.0,Bone marrow failure,2,16718352
2,22.0,Hepatic function abnormal,2,16718352
3,22.0,Nausea,2,16718352
4,22.0,Vomiting,2,16718352
5,22.0,Off label use,6,16718352
0,22.1,White blood cell count decreased,2,16718374
1,22.1,Platelet count decreased,2,16718374
2,22.1,Platelet count decreased,3,16718374
3,22.1,Neutrophil count decreased,2,16718374
4,22.1,Platelet count decreased,2,16718374
0,22.0,Stevens-Johnson syndrome,2,16718418
1,22.0,Hepatic function abnormal,2,16718418
2,22.0,Visual acuity reduced,2,16718418
3,22.0,Eye disorder,2,16718418
0,22.0,Hospitalisation,3,16718444
1,22.0,Gait inability,6,16718444
0,22.0,Musculoskeletal chest pain,3,16718445
0,22.0,Hyponatraemia,2,16718447
0,22.0,Acute kidney injury,2,16718513
0,22.0,Rectal haemorrhage,6,16718539
0,22.0,Depression,6,16718550
1,22.0,Diarrhoea,6,16718550
2,22.0,Fatigue,6,16718550
3,22.0,Confusional state,6,16718550
0,22.0,Neutropenia,3,16718562
0,22.0,Malignant neoplasm progression,3,16718580
1,22.0,Prostatic specific antigen increased,3,16718580
2,22.0,Drug resistance,6,16718580
0,22.0,Palpitations,1,16718585
0,22.0,Periorbital oedema,6,16718628
0,22.0,C-reactive protein increased,1,16718667
1,22.0,General physical health deterioration,1,16718667
0,22.0,Metastases to liver,6,16718690
1,22.0,Diarrhoea,6,16718690
2,22.0,Off label use,6,16718690
0,22.0,Fatigue,6,16718713
1,22.0,Abdominal discomfort,6,16718713
0,22.0,White blood cell count decreased,1,16718723
1,22.0,Decreased appetite,1,16718723
0,22.0,Back pain,1,16718751
1,22.0,Rash,1,16718751
2,22.0,Hypertensive crisis,1,16718751
0,22.0,Pyrexia,6,16718779
1,22.0,Fatigue,6,16718779
2,22.0,Hypertension,6,16718779
3,22.0,Gastrointestinal disorder,6,16718779
4,22.0,Epistaxis,6,16718779
5,22.0,Bone marrow failure,6,16718779
6,22.0,Proteinuria,6,16718779
7,22.0,Alopecia,6,16718779
0,22.0,Death,5,16718785
0,22.0,Transient ischaemic attack,6,16718807
0,22.1,Nephritis,4,16718816
1,22.1,Encephalitis,4,16718816
2,22.1,Colitis,4,16718816
0,22.0,Acute myocardial infarction,6,16718840
1,22.0,Arterial occlusive disease,6,16718840
2,22.0,Rectal haemorrhage,6,16718840
3,22.0,Haemoptysis,6,16718840
4,22.0,Sinus bradycardia,6,16718840
5,22.0,Pulmonary haemorrhage,6,16718840
6,22.0,Arrhythmia,6,16718840
7,22.0,Right ventricular failure,6,16718840
8,22.0,Nephrotic syndrome,6,16718840
9,22.0,Haematuria,6,16718840
10,22.0,Supraventricular extrasystoles,6,16718840
11,22.0,Subgaleal haematoma,6,16718840
12,22.0,Proteinuria,6,16718840
13,22.0,Neutropenia,6,16718840
14,22.0,Anaemia,6,16718840
15,22.0,Silent myocardial infarction,6,16718840
16,22.0,Cardiac failure,6,16718840
17,22.0,Pericarditis,6,16718840
18,22.0,Small intestinal perforation,6,16718840
19,22.0,Appendicitis perforated,6,16718840
20,22.0,Febrile neutropenia,6,16718840
21,22.0,Left ventricular hypertrophy,6,16718840
22,22.0,Arteriosclerosis coronary artery,6,16718840
23,22.0,Subarachnoid haemorrhage,6,16718840
24,22.0,Shock haemorrhagic,6,16718840
25,22.0,Bradycardia,6,16718840
26,22.0,Pneumonia,6,16718840
27,22.0,Ventricular extrasystoles,6,16718840
28,22.0,Tachycardia,6,16718840
29,22.0,Palpitations,6,16718840
30,22.0,Hypertension,6,16718840
31,22.0,Cardiac arrest,6,16718840
32,22.0,Acute coronary syndrome,6,16718840
33,22.0,Atrial fibrillation,6,16718840
34,22.0,Pulmonary oedema,6,16718840
35,22.0,Thrombophlebitis superficial,6,16718840
36,22.0,Myocardial infarction,6,16718840
37,22.0,Ischaemic stroke,6,16718840
38,22.0,Haematemesis,6,16718840
39,22.0,Deep vein thrombosis,6,16718840
40,22.0,Pulmonary embolism,6,16718840
41,22.0,Asthenia,6,16718840
42,22.0,Petechiae,6,16718840
43,22.0,Paget-Schroetter syndrome,6,16718840
44,22.0,Left ventricular dysfunction,6,16718840
45,22.0,Blood pressure systolic increased,6,16718840
46,22.0,Cardiovascular insufficiency,6,16718840
47,22.0,Myocardial ischaemia,6,16718840
48,22.0,Cardio-respiratory arrest,6,16718840
49,22.0,Hypertensive crisis,6,16718840
50,22.0,Pulmonary infarction,6,16718840
51,22.0,Subclavian vein thrombosis,6,16718840
52,22.0,Peritonitis,6,16718840
53,22.0,Disease progression,6,16718840
54,22.0,Epistaxis,6,16718840
55,22.0,Metabolic cardiomyopathy,6,16718840
56,22.0,Ejection fraction decreased,6,16718840
57,22.0,Haematochezia,6,16718840
58,22.0,Embolism arterial,6,16718840
59,22.0,Pericardial effusion,6,16718840
60,22.0,Cardiomyopathy,6,16718840
61,22.0,Gingival bleeding,6,16718840
62,22.0,Cardiac septal hypertrophy,6,16718840
63,22.0,Venous thrombosis,6,16718840
64,22.0,Supraventricular tachycardia,6,16718840
65,22.0,Mitral valve disease,6,16718840
0,22.1,Gingival bleeding,6,16718851
1,22.1,Glossitis,6,16718851
2,22.1,Blood pressure increased,6,16718851
3,22.1,Infection,3,16718851
4,22.1,Oropharyngeal pain,6,16718851
5,22.1,Epistaxis,1,16718851
6,22.1,Gingival blister,1,16718851
7,22.1,Dry mouth,6,16718851
8,22.1,Oral pain,6,16718851
9,22.1,Tooth disorder,6,16718851
10,22.1,Feeding disorder,1,16718851
11,22.1,Blister,6,16718851
0,22.0,Skin exfoliation,6,16718852
0,22.1,Frequent bowel movements,6,16718855
1,22.1,Fatigue,3,16718855
2,22.1,Diarrhoea,3,16718855
3,22.1,Decreased appetite,3,16718855
4,22.1,Hypothyroidism,3,16718855
5,22.1,Faeces soft,6,16718855
6,22.1,Vitamin D decreased,6,16718855
7,22.1,Depression,3,16718855
8,22.1,Hypertension,2,16718855
9,22.1,Vomiting,3,16718855
10,22.1,Headache,1,16718855
11,22.1,Nausea,3,16718855
12,22.1,Dehydration,6,16718855
0,22.0,Nausea,6,16718857
0,22.0,Death,5,16718910
0,22.0,Anaemia,3,16718927
1,22.0,Thrombocytopenia,3,16718927
2,22.0,Leukopenia,3,16718927
0,22.0,Lactic acidosis,3,16718939
1,22.0,Sepsis,1,16718939
2,22.0,Hyperlactacidaemia,3,16718939
0,22.0,Vomiting,1,16718959
1,22.0,Drug interaction,6,16718959
2,22.0,Off label use,6,16718959
3,22.0,Hypokalaemia,1,16718959
4,22.0,Febrile neutropenia,1,16718959
0,22.0,Cerebrovascular accident,6,16718967
0,22.0,Oedema,6,16718971
1,22.0,Dyspnoea,6,16718971
2,22.0,Asthenia,6,16718971
3,22.0,Fatigue,6,16718971
4,22.0,Pain,6,16718971
0,22.0,Malignant neoplasm progression,6,16718985
0,22.0,Delirium,6,16718993
0,22.0,Hypophosphataemia,1,16719070
0,22.1,Pneumonia,6,16719101
1,22.1,Abdominal discomfort,1,16719101
2,22.1,Haemoglobin decreased,6,16719101
3,22.1,Fluid retention,6,16719101
4,22.1,Influenza,6,16719101
0,22.0,Lichen planus,2,16719110
0,22.0,Daydreaming,1,16719134
0,22.0,Renal impairment,6,16719143
1,22.0,Bone marrow failure,6,16719143
0,22.0,Sodium retention,6,16719206
1,22.0,Neurotoxicity,6,16719206
2,22.0,Alopecia,6,16719206
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16719206
4,22.0,Fluid retention,6,16719206
5,22.0,White blood cell count decreased,6,16719206
6,22.0,Haemoglobin decreased,6,16719206
0,22.0,Neuropathy peripheral,6,16719215
1,22.0,Bone pain,2,16719215
2,22.0,Hypertension,3,16719215
3,22.0,Transient ischaemic attack,6,16719215
4,22.0,Vomiting,6,16719215
5,22.0,Mastitis,6,16719215
6,22.0,Platelet count decreased,6,16719215
7,22.0,Cancer pain,6,16719215
8,22.0,Decreased interest,6,16719215
9,22.0,Rectal tenesmus,6,16719215
10,22.0,Anxiety,6,16719215
11,22.0,Fatigue,3,16719215
12,22.0,Cardiac failure congestive,6,16719215
13,22.0,Migraine,6,16719215
14,22.0,Post-traumatic stress disorder,6,16719215
15,22.0,Urinary incontinence,6,16719215
16,22.0,Insomnia,3,16719215
17,22.0,Abdominal pain upper,6,16719215
18,22.0,Depression,6,16719215
19,22.0,Blood cholesterol increased,6,16719215
20,22.0,Back pain,6,16719215
21,22.0,Asthenia,3,16719215
22,22.0,Ascites,6,16719215
23,22.0,Weight increased,6,16719215
24,22.0,Neuralgia,6,16719215
25,22.0,Tremor,6,16719215
26,22.0,Nausea,3,16719215
0,22.0,Rash,6,16719227
0,22.0,Hepatitis cholestatic,1,16719257
0,22.0,International normalised ratio increased,1,16719294
1,22.0,Gingival bleeding,1,16719294
2,22.0,Urinary bladder haemorrhage,1,16719294
3,22.0,Abdominal wall haematoma,1,16719294
4,22.0,Drug interaction,6,16719294
5,22.0,Haematuria,1,16719294
6,22.0,Ear haemorrhage,1,16719294
7,22.0,Haematoma muscle,1,16719294
8,22.0,Haemorrhage subcutaneous,1,16719294
0,22.0,Fatigue,6,16719315
1,22.0,Weight decreased,6,16719315
2,22.0,Blood bilirubin,6,16719315
3,22.0,Nausea,6,16719315
4,22.0,Aspartate aminotransferase increased,6,16719315
5,22.0,Gamma-glutamyltransferase increased,6,16719315
6,22.0,Blood alkaline phosphatase,6,16719315
7,22.0,Neuropathy peripheral,6,16719315
8,22.0,Neutropenia,6,16719315
9,22.0,Blood albumin abnormal,6,16719315
10,22.0,Abdominal pain upper,6,16719315
11,22.0,Alanine aminotransferase increased,6,16719315
0,22.1,Enterocolitis infectious,1,16719339
1,22.1,Pneumonia,1,16719339
0,22.0,Mobility decreased,6,16719359
0,22.1,Rash,3,16719432
1,22.1,Pneumonitis,6,16719432
2,22.1,Hypersensitivity,6,16719432
0,22.1,Hypotension,1,16719476
0,22.0,Death,5,16719507
0,22.0,Completed suicide,5,16719520
0,22.1,Blood count abnormal,6,16719587
1,22.1,Muscle spasms,3,16719587
2,22.1,Anaemia,6,16719587
3,22.1,Pruritus,6,16719587
4,22.1,Hypertension,2,16719587
5,22.1,Alopecia,3,16719587
6,22.1,Sleep apnoea syndrome,6,16719587
7,22.1,Asthenia,3,16719587
8,22.1,Back pain,1,16719587
9,22.1,Dizziness,1,16719587
10,22.1,Blood potassium decreased,1,16719587
11,22.1,Dehydration,6,16719587
12,22.1,Vomiting,1,16719587
13,22.1,Drug ineffective,6,16719587
14,22.1,Blood magnesium decreased,3,16719587
15,22.1,Glucose tolerance impaired,6,16719587
16,22.1,Loss of personal independence in daily activities,6,16719587
17,22.1,Nausea,1,16719587
18,22.1,Myalgia,3,16719587
19,22.1,Tremor,6,16719587
20,22.1,Dry skin,2,16719587
21,22.1,Fatigue,3,16719587
22,22.1,Rash pruritic,6,16719587
0,22.0,Drug intolerance,6,16719619
1,22.0,Weight decreased,3,16719619
2,22.0,Diarrhoea,3,16719619
3,22.0,Fatigue,6,16719619
4,22.0,Intentional dose omission,6,16719619
5,22.0,Small intestinal obstruction,6,16719619
6,22.0,Constipation,3,16719619
7,22.0,Vomiting,3,16719619
8,22.0,Malaise,6,16719619
9,22.0,Hypophagia,3,16719619
10,22.0,Dehydration,6,16719619
0,22.0,Drug interaction,6,16719678
1,22.0,Hypoglycaemia,1,16719678
0,22.0,Acute lymphocytic leukaemia,3,16719700
1,22.0,Second primary malignancy,3,16719700
2,22.0,Neoplasm progression,3,16719700
0,22.0,Second primary malignancy,6,16719706
0,22.1,Muscle spasms,6,16719714
1,22.1,Vomiting,6,16719714
2,22.1,Immune system disorder,6,16719714
3,22.1,Oesophageal infection,6,16719714
4,22.1,Alopecia,6,16719714
5,22.1,Diarrhoea,6,16719714
6,22.1,Aphasia,6,16719714
0,22.1,Nail disorder,3,16719751
1,22.1,Dry skin,3,16719751
2,22.1,Nail growth abnormal,3,16719751
3,22.1,Onycholysis,3,16719751
0,22.0,Panic reaction,6,16719769
0,22.0,Second primary malignancy,6,16719775
1,22.0,Off label use,6,16719775
2,22.0,Product use in unapproved indication,6,16719775
3,22.0,Acute myeloid leukaemia,6,16719775
0,22.0,Rash,6,16719779
0,22.0,Neoplasm progression,6,16719781
1,22.0,Second primary malignancy,6,16719781
2,22.0,Phyllodes tumour,6,16719781
0,22.0,Death,5,16719786
0,22.1,White blood cell count decreased,1,16719830
1,22.1,Full blood count decreased,1,16719830
2,22.1,Alopecia,1,16719830
0,22.1,Rash,,16719839
0,22.0,Hypophysitis,2,16719842
0,22.0,Fatigue,6,16719875
0,22.1,Tearfulness,6,16719895
1,22.1,Stomatitis,3,16719895
2,22.1,Arthralgia,6,16719895
3,22.1,Acne,6,16719895
4,22.1,Fatigue,3,16719895
5,22.1,Headache,6,16719895
6,22.1,Back pain,6,16719895
7,22.1,Neck pain,6,16719895
0,22.0,Anaemia,6,16719905
0,22.0,Insomnia,1,16719913
1,22.0,Decreased appetite,1,16719913
2,22.0,Confusional state,1,16719913
3,22.0,Dehydration,1,16719913
4,22.0,Dry mouth,3,16719913
0,22.0,Faeces soft,6,16719949
0,22.0,Fear-related avoidance of activities,6,16719955
1,22.0,Quality of life decreased,6,16719955
2,22.0,Nausea,3,16719955
3,22.0,Balance disorder,6,16719955
4,22.0,Loss of consciousness,6,16719955
5,22.0,Memory impairment,6,16719955
0,22.1,Pulmonary congestion,6,16719976
1,22.1,Pneumonitis,6,16719976
2,22.1,Gastrooesophageal reflux disease,2,16719976
3,22.1,Neoplasm progression,6,16719976
0,22.0,Platelet count decreased,,16719977
0,22.1,Neutrophil count decreased,6,16719980
0,22.0,Death,,16719988
0,22.1,Fatigue,1,16719992
1,22.1,Irritability,6,16719992
2,22.1,Asphyxia,6,16719992
3,22.1,Feeling of despair,6,16719992
4,22.1,Asthenia,1,16719992
5,22.1,Myalgia,6,16719992
6,22.1,Somnolence,6,16719992
7,22.1,Anxiety,6,16719992
8,22.1,White blood cell count abnormal,6,16719992
9,22.1,White blood cell count decreased,6,16719992
0,22.0,Therapy cessation,,16720001
1,22.0,Haemoglobin decreased,,16720001
0,22.1,Vomiting,3,16720003
1,22.1,Small intestinal obstruction,3,16720003
2,22.1,Fatigue,3,16720003
3,22.1,Nausea,3,16720003
4,22.1,Insomnia,2,16720003
5,22.1,Blood pressure increased,6,16720003
6,22.1,Carbohydrate antigen 125 increased,6,16720003
0,22.0,Death,,16720025
0,22.0,Rash generalised,6,16720031
1,22.0,Laryngeal oedema,6,16720031
2,22.0,Pyrexia,6,16720031
3,22.0,Swelling,6,16720031
4,22.0,Swelling face,6,16720031
0,22.0,Death,5,16720036
0,22.1,Transient acantholytic dermatosis,1,16720058
0,22.1,Cough,,16720061
0,22.1,Cytopenia,6,16720077
1,22.1,Anaemia,1,16720077
2,22.1,Blood count abnormal,1,16720077
3,22.1,Death,5,16720077
4,22.1,Urinary tract infection,6,16720077
0,22.1,Diarrhoea,1,16720080
0,22.0,Hot flush,6,16720089
0,22.0,Neoplasm progression,6,16720098
0,22.1,Weight decreased,6,16720117
1,22.1,Neoplasm progression,6,16720117
2,22.1,Decreased appetite,6,16720117
3,22.1,Thrombocytopenia,6,16720117
4,22.1,Pleural effusion,6,16720117
5,22.1,Abdominal discomfort,6,16720117
6,22.1,Nausea,6,16720117
7,22.1,Dyspnoea,6,16720117
8,22.1,Vomiting,6,16720117
9,22.1,Full blood count decreased,6,16720117
10,22.1,Diarrhoea,6,16720117
11,22.1,Pyrexia,6,16720117
0,22.0,Pleural effusion,6,16720138
1,22.0,Pulmonary thrombosis,6,16720138
0,22.0,Colitis,1,16720179
0,22.0,Transaminases increased,4,16720182
1,22.0,Hepatotoxicity,4,16720182
0,22.0,Pyrexia,6,16720207
1,22.0,Chills,6,16720207
2,22.0,Nausea,6,16720207
3,22.0,Vision blurred,6,16720207
4,22.0,Rash,6,16720207
0,22.1,Arthralgia,,16720215
1,22.1,Decreased appetite,,16720215
2,22.1,Arthritis,,16720215
3,22.1,Dry skin,,16720215
4,22.1,Weight decreased,,16720215
5,22.1,Peripheral swelling,,16720215
6,22.1,Erythema,2,16720215
7,22.1,Urinary tract infection,1,16720215
8,22.1,Blood pressure increased,,16720215
9,22.1,Neuropathy peripheral,,16720215
10,22.1,Gait disturbance,,16720215
11,22.1,Off label use,,16720215
0,22.1,Encephalopathy,,16720251
0,22.0,Throat tightness,1,16720255
0,22.0,Pyrexia,6,16720281
1,22.0,Dyspnoea,6,16720281
2,22.0,Drug interaction,6,16720281
3,22.0,Nausea,3,16720281
4,22.0,Atrioventricular dissociation,6,16720281
5,22.0,Heart rate decreased,6,16720281
6,22.0,Apparent death,6,16720281
7,22.0,Dizziness,3,16720281
8,22.0,Fatigue,6,16720281
0,22.0,Infection,6,16720290
1,22.0,Product dose omission,6,16720290
0,22.0,Venous thrombosis,2,16720302
1,22.0,Infusion related reaction,2,16720302
0,22.0,Death,5,16720304
1,22.0,Fatigue,5,16720304
2,22.0,Neoplasm progression,5,16720304
0,22.1,Atrial fibrillation,,16720305
0,22.0,Febrile bone marrow aplasia,1,16720307
0,22.0,Hypomagnesaemia,3,16720331
1,22.0,Nausea,1,16720331
2,22.0,Acute kidney injury,1,16720331
3,22.0,Vomiting,1,16720331
4,22.0,Hypokalaemia,1,16720331
0,22.0,Asphyxia,5,16720337
0,22.0,Pulmonary embolism,5,16720340
1,22.0,Pulmonary hypertension,6,16720340
2,22.0,Neoplasm progression,3,16720340
0,22.1,Adverse reaction,,16720352
0,22.0,Intentional overdose,1,16720365
1,22.0,Diabetes mellitus inadequate control,1,16720365
2,22.0,Injection site pain,1,16720365
3,22.0,Respiratory disorder,1,16720365
0,22.0,"Hallucinations, mixed",1,16720388
0,22.1,Device occlusion,1,16720392
1,22.1,Bacteraemia,1,16720392
2,22.1,Urinary tract infection,1,16720392
0,22.0,Speech disorder,3,16720395
1,22.0,Blood sodium decreased,3,16720395
2,22.0,Blood glucose increased,3,16720395
3,22.0,Wrong product administered,6,16720395
4,22.0,Decreased appetite,3,16720395
5,22.0,Somnolence,3,16720395
6,22.0,Hypersomnia,1,16720395
0,22.0,Autoimmune thyroiditis,6,16720398
1,22.0,Diabetic ketoacidosis,1,16720398
2,22.0,Immune-mediated adverse reaction,1,16720398
0,22.0,Colitis,1,16720402
0,22.1,Disease progression,,16720432
0,22.0,Malignant neoplasm progression,6,16720451
0,22.1,Pruritus,,16720459
1,22.1,Erythema,,16720459
0,22.1,Weight increased,6,16720463
1,22.1,Odynophagia,6,16720463
2,22.1,Nausea,6,16720463
3,22.1,Musculoskeletal chest pain,6,16720463
4,22.1,Gastrooesophageal reflux disease,6,16720463
5,22.1,Decreased appetite,6,16720463
6,22.1,Increased appetite,6,16720463
7,22.1,Cough,6,16720463
8,22.1,Weight decreased,6,16720463
9,22.1,Fatigue,6,16720463
10,22.1,Alopecia,6,16720463
11,22.1,Fungal pharyngitis,6,16720463
0,22.1,Diarrhoea,6,16720475
1,22.1,Nausea,6,16720475
2,22.1,Intentional dose omission,6,16720475
3,22.1,Bone marrow failure,6,16720475
4,22.1,Fatigue,6,16720475
5,22.1,Epistaxis,2,16720475
6,22.1,Nasopharyngitis,1,16720475
7,22.1,Alopecia,6,16720475
8,22.1,Cough,6,16720475
9,22.1,Sneezing,6,16720475
10,22.1,White blood cell count decreased,2,16720475
11,22.1,Infection,1,16720475
12,22.1,Dry mouth,6,16720475
0,22.0,Acute coronary syndrome,6,16720494
0,22.1,Administration site extravasation,1,16720499
1,22.1,Dyspnoea,3,16720499
0,22.1,Hospice care,,16720510
0,22.0,Death,5,16720526
0,22.1,Injection site warmth,6,16720534
1,22.1,Skin discolouration,6,16720534
2,22.1,Hypoaesthesia,6,16720534
3,22.1,Injection site erythema,6,16720534
4,22.1,Injection site cellulitis,6,16720534
5,22.1,Injection site inflammation,6,16720534
6,22.1,Gangrene,6,16720534
7,22.1,Blood pressure decreased,6,16720534
8,22.1,Injection site pain,6,16720534
0,22.1,Haemoglobin decreased,,16720596
1,22.1,Pleural effusion,,16720596
2,22.1,Dyspnoea,,16720596
3,22.1,Gastrointestinal ulcer,,16720596
0,22.1,Lymphopenia,1,16720615
1,22.1,Acute kidney injury,1,16720615
2,22.1,Diarrhoea,1,16720615
3,22.1,Neutropenia,1,16720615
0,22.0,Intentional product misuse,6,16720622
1,22.0,Venous thrombosis limb,6,16720622
0,22.0,Constipation,6,16720664
1,22.0,Fatigue,6,16720664
2,22.0,Colon cancer metastatic,1,16720664
3,22.0,Retroperitoneal lymphadenopathy,1,16720664
4,22.0,Toxicity to various agents,6,16720664
5,22.0,Malignant neoplasm progression,1,16720664
6,22.0,Rash,6,16720664
0,22.1,Neutropenia,1,16720723
1,22.1,Off label use,6,16720723
2,22.1,Autoimmune pancreatitis,2,16720723
3,22.1,Amylase increased,2,16720723
4,22.1,Decreased appetite,2,16720723
5,22.1,Infection,2,16720723
0,22.0,Renal failure,5,16720781
0,22.0,Hypophagia,6,16720803
1,22.0,Malaise,6,16720803
2,22.0,Body temperature increased,6,16720803
3,22.0,Hypotension,6,16720803
4,22.0,Tachypnoea,6,16720803
5,22.0,Vomiting,6,16720803
6,22.0,Neutropenic sepsis,5,16720803
7,22.0,Malaise,6,16720803
8,22.0,Stomatitis,6,16720803
9,22.0,Oropharyngeal pain,6,16720803
10,22.0,Nausea,6,16720803
11,22.0,Hypoxia,6,16720803
12,22.0,Oral candidiasis,6,16720803
13,22.0,Arrhythmia,3,16720803
14,22.0,Tachycardia,6,16720803
15,22.0,Productive cough,6,16720803
0,22.1,Incorrect dose administered,6,16720833
1,22.1,Prostate cancer,2,16720833
0,22.0,Prostate cancer,6,16720847
0,22.0,Neuropathy peripheral,6,16720918
1,22.0,Skin disorder,6,16720918
0,22.1,Post procedural bile leak,6,16720933
1,22.1,Venoocclusive liver disease,6,16720933
0,22.0,Gingivitis,3,16720969
1,22.0,Osteonecrosis of jaw,3,16720969
0,22.0,Neck pain,3,16720970
1,22.0,Vomiting,3,16720970
2,22.0,Nausea,3,16720970
3,22.0,Back pain,3,16720970
4,22.0,Hypophagia,3,16720970
5,22.0,Bone pain,3,16720970
0,22.1,Blood bilirubin increased,3,16720996
1,22.1,Liver operation,6,16720996
2,22.1,Rash,3,16720996
3,22.1,Toxicity to various agents,6,16720996
4,22.1,Pruritus,6,16720996
5,22.1,Hypotension,6,16720996
6,22.1,Gallbladder operation,6,16720996
7,22.1,Pancreatitis,6,16720996
8,22.1,Pneumonia,6,16720996
9,22.1,Dry skin,6,16720996
10,22.1,Venous injury,6,16720996
0,22.0,Osteonecrosis of jaw,6,16721007
1,22.0,Tooth extraction,6,16721007
0,22.0,Drug eruption,1,16721045
1,22.0,Decreased appetite,6,16721045
2,22.0,Skin infection,2,16721045
3,22.0,Photosensitivity reaction,2,16721045
4,22.0,Rash,1,16721045
0,22.0,Asthenia,6,16721178
1,22.0,Vomiting,6,16721178
2,22.0,Adverse event,6,16721178
0,22.0,Death,5,16721275
0,22.0,Hair disorder,3,16721297
1,22.0,Hair texture abnormal,3,16721297
2,22.0,Hair colour changes,3,16721297
3,22.0,Alopecia,3,16721297
0,22.0,Alopecia,3,16721302
1,22.0,Hair colour changes,3,16721302
2,22.0,Hair disorder,3,16721302
3,22.0,Hair texture abnormal,3,16721302
4,22.0,Madarosis,3,16721302
0,22.0,Hot flush,6,16721314
0,22.0,Alopecia,2,16721322
1,22.0,Arthralgia,6,16721322
2,22.0,White blood cell count decreased,6,16721322
3,22.0,Fatigue,2,16721322
0,22.1,Product dispensing error,6,16721326
1,22.1,Gastric dilatation,6,16721326
2,22.1,Platelet count decreased,6,16721326
3,22.1,Tumour marker increased,3,16721326
4,22.1,Alopecia,6,16721326
5,22.1,Fatigue,6,16721326
6,22.1,Confusional state,6,16721326
7,22.1,Stress,6,16721326
0,22.1,Pneumonitis,4,16721358
1,22.1,Leukopenia,6,16721358
2,22.1,Coronary artery disease,6,16721358
0,22.0,Blindness transient,6,16721374
1,22.0,Optic disc hyperaemia,6,16721374
2,22.0,Optic disc disorder,6,16721374
0,22.0,Malignant neoplasm progression,5,16721375
1,22.0,Metastases to lymph nodes,6,16721375
2,22.0,Radiation pneumonitis,2,16721375
0,22.1,Back pain,6,16721390
1,22.1,Pain in extremity,6,16721390
2,22.1,Arthralgia,6,16721390
3,22.1,Arthropathy,6,16721390
0,22.0,Hypertension,6,16721407
0,22.1,Hyponatraemia,1,16721410
0,22.1,Haematotoxicity,6,16721435
0,22.0,Second primary malignancy,5,16721436
1,22.0,Acute myeloid leukaemia,5,16721436
2,22.0,Cardiotoxicity,5,16721436
0,22.0,Death,5,16721439
0,22.0,Gastrointestinal perforation,5,16721596
1,22.0,Drug interaction,5,16721596
0,22.0,Cervix carcinoma,6,16721620
0,22.0,Metastases to central nervous system,2,16721640
1,22.0,Metastases to spine,6,16721640
2,22.0,Metastases to neck,6,16721640
3,22.0,White blood cell count decreased,6,16721640
4,22.0,Metastases to bone,6,16721640
0,22.0,Hypoglycaemia,6,16721668
1,22.0,Hyperhidrosis,6,16721668
2,22.0,Nausea,6,16721668
3,22.0,Drug intolerance,6,16721668
4,22.0,Fatigue,6,16721668
5,22.0,Disease progression,6,16721668
0,22.1,Cardiac arrest,6,16721682
1,22.1,Cardiac disorder,6,16721682
2,22.1,Cerebrovascular accident,6,16721682
3,22.1,Bone cancer,6,16721682
4,22.1,Thrombosis,6,16721682
5,22.1,Cholecystitis infective,6,16721682
0,22.0,Asthenia,3,16721748
1,22.0,Diarrhoea,1,16721748
2,22.0,Febrile bone marrow aplasia,3,16721748
